V. Chavan, Avinash and Gandhimathi, R. (2023) Quality by Design Approach: Progress in Pharmaceutical method Development and Validation. Biomedical and Pharmacology Journal, 16 (3). pp. 1669-1679. ISSN 09746242
![[thumbnail of BPJ_Vol_16_No_3_p_1669-1679 (1).pdf]](https://ir.vistas.ac.in/style/images/fileicons/archive.png)
BPJ_Vol_16_No_3_p_1669-1679 (1).pdf
Download (290kB)
Abstract
Pharmaceutical analysis plays a significant role in pharmaceutical formulation quality assurance and control. Due to the pharmaceutical industries’ rapid expansion and the production of pharmaceuticals all over the world, there is a greater need for novel analytical procedures in this sector. Establishing the identification, purity, physical properties, and potency of medications as well as the medication’s bioavailability and stability is the goal of
analytical method development. A few new drug applications were recently given regulatory flexibility by the Food and Drug Administration for an analytical method based on quality by design. With Quality by design, product design and development are performed methodically. Analytical methodologies have similar opportunities for implementing Quality by design as production procedures do. It consequently enhances formulation design, development efficiency, and capacity. The underpinnings of the QbD approach have been explored in this article due to
their use in the creation and validation of analytical procedures. Additionally, a summary of experimental studies reporting the application of the QbD methodology to method development is include
Item Type: | Article |
---|---|
Subjects: | Pharmaceutical Chemistry and Analysis > Pharmaceutical Analysis |
Divisions: | Pharmaceutical Chemistry and Analysis |
Depositing User: | Mr IR Admin |
Date Deposited: | 13 Sep 2024 11:09 |
Last Modified: | 13 Sep 2024 11:09 |
URI: | https://ir.vistas.ac.in/id/eprint/5948 |